Bill Status of HB2469  98th General Assembly

Short Description:  MEDICAID-ANTIPSYCHOTIC MEDS

House Sponsors
Rep. Linda Chapa LaVia - Naomi D. Jakobsson - Greg Harris, David R. Leitch, William Davis, Esther Golar, Elizabeth Hernandez and Robyn Gabel

Last Action
DateChamber Action
  12/3/2014HouseSession Sine Die

Statutes Amended In Order of Appearance
305 ILCS 5/5-5.12from Ch. 23, par. 5-5.12


Synopsis As Introduced
Amends the Medical Assistance Article of the Illinois Public Aid Code. Provides that antipsychotic and anticonvulsant drugs used to treat severe mental illness shall not be subject to prior approval as a result of the 4-prescription limit and shall not count toward the monthly prescription limit when used for the following mental disorders: post-traumatic stress disorder, schizophrenia, schizoaffective disorder, bipolar disorder, or panic disorder. Effective January 1, 2014.

 Fiscal Note (Dept. of Healthcare & Family Services)
 Passage of this bill creates a potential increase in Healthcare and Family Services cost for antipsychotic and anticonvulsant drugs. FY14 estimate is projected at $4.9 million ($4.1 million adults and $.8 million children). Additional cost is based on FY12 data.

Actions 
DateChamber Action
  2/20/2013HouseFiled with the Clerk by Rep. Linda Chapa LaVia
  2/20/2013HouseFirst Reading
  2/20/2013HouseReferred to Rules Committee
  3/1/2013HouseAdded Chief Co-Sponsor Rep. Naomi D. Jakobsson
  3/5/2013HouseAdded Chief Co-Sponsor Rep. Greg Harris
  3/5/2013HouseAdded Co-Sponsor Rep. David R. Leitch
  4/22/2013HouseFiscal Note Filed
  2/5/2014HouseAdded Co-Sponsor Rep. William Davis
  3/5/2014HouseAdded Co-Sponsor Rep. Esther Golar
  3/10/2014HouseAdded Co-Sponsor Rep. Elizabeth Hernandez
  4/1/2014HouseAdded Co-Sponsor Rep. Robyn Gabel
  12/3/2014HouseSession Sine Die